The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Micafungin Sodium for Injection-Global Market Insights and Sales Trends 2025
Synopsis
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
The global Micafungin Sodium for Injection market size is expected to reach US$ 286.8 million by 2029, growing at a CAGR of -2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Micafungin Sodium for Injection in various end use industries. The expanding demands from the Candidemia, Respiratory Mycosis and Gastrointestinal Mycosis,, are propelling Micafungin Sodium for Injection market. 50 mg Single-use Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 100 mg Single-use Vial segment is estimated at % CAGR for the next seven-year period.
North America is the largest Micafungin Sodium for Injection market with about 28% market share. Europe is follower, accounting for about 26% market share.
The key players are Astellas etc. Astellas occupied about 97% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Micafungin Sodium for Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Micafungin Sodium for Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Micafungin Sodium for Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Micafungin Sodium for Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Micafungin Sodium for Injection covered in this report include Astellas. etc.
The global Micafungin Sodium for Injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Astellas
Global Micafungin Sodium for Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Micafungin Sodium for Injection market, Segment by Type:
50 mg Single-use Vial
100 mg Single-use Vial
Global Micafungin Sodium for Injection market, by Application
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Micafungin Sodium for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Micafungin Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
The global Micafungin Sodium for Injection market size is expected to reach US$ 286.8 million by 2029, growing at a CAGR of -2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Micafungin Sodium for Injection in various end use industries. The expanding demands from the Candidemia, Respiratory Mycosis and Gastrointestinal Mycosis,, are propelling Micafungin Sodium for Injection market. 50 mg Single-use Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 100 mg Single-use Vial segment is estimated at % CAGR for the next seven-year period.
North America is the largest Micafungin Sodium for Injection market with about 28% market share. Europe is follower, accounting for about 26% market share.
The key players are Astellas etc. Astellas occupied about 97% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Micafungin Sodium for Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Micafungin Sodium for Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Micafungin Sodium for Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Micafungin Sodium for Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Micafungin Sodium for Injection covered in this report include Astellas. etc.
The global Micafungin Sodium for Injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Astellas
Global Micafungin Sodium for Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Micafungin Sodium for Injection market, Segment by Type:
50 mg Single-use Vial
100 mg Single-use Vial
Global Micafungin Sodium for Injection market, by Application
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Micafungin Sodium for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Micafungin Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Micafungin Sodium for Injection Market Overview
1.1 Micafungin Sodium for Injection Product Overview
1.2 Micafungin Sodium for Injection Market Segment by Type
1.2.1 50 mg Single-use Vial
1.2.2 100 mg Single-use Vial
1.3 Global Micafungin Sodium for Injection Market Size by Type
1.3.1 Global Micafungin Sodium for Injection Market Size Overview by Type (2018-2029)
1.3.2 Global Micafungin Sodium for Injection Historic Market Size Review by Type (2018-2023)
1.3.3 Global Micafungin Sodium for Injection Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Micafungin Sodium for Injection Sales Breakdown by Type (2018-2023)
1.4.2 Europe Micafungin Sodium for Injection Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Micafungin Sodium for Injection Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Micafungin Sodium for Injection Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Micafungin Sodium for Injection Sales Breakdown by Type (2018-2023)
2 Global Micafungin Sodium for Injection Market Competition by Company
2.1 Global Top Players by Micafungin Sodium for Injection Sales (2018-2023)
2.2 Global Top Players by Micafungin Sodium for Injection Revenue (2018-2023)
2.3 Global Top Players by Micafungin Sodium for Injection Price (2018-2023)
2.4 Global Top Manufacturers Micafungin Sodium for Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Micafungin Sodium for Injection Market Competitive Situation and Trends
2.5.1 Micafungin Sodium for Injection Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Micafungin Sodium for Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Micafungin Sodium for Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Micafungin Sodium for Injection Market
2.8 Key Manufacturers Micafungin Sodium for Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Micafungin Sodium for Injection Status and Outlook by Region
3.1 Global Micafungin Sodium for Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Micafungin Sodium for Injection Historic Market Size by Region
3.2.1 Global Micafungin Sodium for Injection Sales in Volume by Region (2018-2023)
3.2.2 Global Micafungin Sodium for Injection Sales in Value by Region (2018-2023)
3.2.3 Global Micafungin Sodium for Injection Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Micafungin Sodium for Injection Forecasted Market Size by Region
3.3.1 Global Micafungin Sodium for Injection Sales in Volume by Region (2024-2029)
3.3.2 Global Micafungin Sodium for Injection Sales in Value by Region (2024-2029)
3.3.3 Global Micafungin Sodium for Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Micafungin Sodium for Injection by Application
4.1 Micafungin Sodium for Injection Market Segment by Application
4.1.1 Candidemia
4.1.2 Respiratory Mycosis
4.1.3 Gastrointestinal Mycosis
4.2 Global Micafungin Sodium for Injection Market Size by Application
4.2.1 Global Micafungin Sodium for Injection Market Size Overview by Application (2018-2029)
4.2.2 Global Micafungin Sodium for Injection Historic Market Size Review by Application (2018-2023)
4.2.3 Global Micafungin Sodium for Injection Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Micafungin Sodium for Injection Sales Breakdown by Application (2018-2023)
4.3.2 Europe Micafungin Sodium for Injection Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Micafungin Sodium for Injection Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Micafungin Sodium for Injection Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Micafungin Sodium for Injection Sales Breakdown by Application (2018-2023)
5 North America Micafungin Sodium for Injection by Country
5.1 North America Micafungin Sodium for Injection Historic Market Size by Country
5.1.1 North America Micafungin Sodium for Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Micafungin Sodium for Injection Sales in Volume by Country (2018-2023)
5.1.3 North America Micafungin Sodium for Injection Sales in Value by Country (2018-2023)
5.2 North America Micafungin Sodium for Injection Forecasted Market Size by Country
5.2.1 North America Micafungin Sodium for Injection Sales in Volume by Country (2024-2029)
5.2.2 North America Micafungin Sodium for Injection Sales in Value by Country (2024-2029)
6 Europe Micafungin Sodium for Injection by Country
6.1 Europe Micafungin Sodium for Injection Historic Market Size by Country
6.1.1 Europe Micafungin Sodium for Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Micafungin Sodium for Injection Sales in Volume by Country (2018-2023)
6.1.3 Europe Micafungin Sodium for Injection Sales in Value by Country (2018-2023)
6.2 Europe Micafungin Sodium for Injection Forecasted Market Size by Country
6.2.1 Europe Micafungin Sodium for Injection Sales in Volume by Country (2024-2029)
6.2.2 Europe Micafungin Sodium for Injection Sales in Value by Country (2024-2029)
7 Asia-Pacific Micafungin Sodium for Injection by Region
7.1 Asia-Pacific Micafungin Sodium for Injection Historic Market Size by Region
7.1.1 Asia-Pacific Micafungin Sodium for Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Micafungin Sodium for Injection Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Micafungin Sodium for Injection Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Micafungin Sodium for Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Micafungin Sodium for Injection Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Micafungin Sodium for Injection Sales in Value by Region (2024-2029)
8 Latin America Micafungin Sodium for Injection by Country
8.1 Latin America Micafungin Sodium for Injection Historic Market Size by Country
8.1.1 Latin America Micafungin Sodium for Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Micafungin Sodium for Injection Sales in Volume by Country (2018-2023)
8.1.3 Latin America Micafungin Sodium for Injection Sales in Value by Country (2018-2023)
8.2 Latin America Micafungin Sodium for Injection Forecasted Market Size by Country
8.2.1 Latin America Micafungin Sodium for Injection Sales in Volume by Country (2024-2029)
8.2.2 Latin America Micafungin Sodium for Injection Sales in Value by Country (2024-2029)
9 Middle East and Africa Micafungin Sodium for Injection by Country
9.1 Middle East and Africa Micafungin Sodium for Injection Historic Market Size by Country
9.1.1 Middle East and Africa Micafungin Sodium for Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Micafungin Sodium for Injection Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Micafungin Sodium for Injection Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Micafungin Sodium for Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Micafungin Sodium for Injection Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Micafungin Sodium for Injection Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Astellas
10.1.1 Astellas Company Information
10.1.2 Astellas Introduction and Business Overview
10.1.3 Astellas Micafungin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Astellas Micafungin Sodium for Injection Products Offered
10.1.5 Astellas Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Micafungin Sodium for Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Micafungin Sodium for Injection Industrial Chain Analysis
11.4 Micafungin Sodium for Injection Market Dynamics
11.4.1 Micafungin Sodium for Injection Industry Trends
11.4.2 Micafungin Sodium for Injection Market Drivers
11.4.3 Micafungin Sodium for Injection Market Challenges
11.4.4 Micafungin Sodium for Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Micafungin Sodium for Injection Distributors
12.3 Micafungin Sodium for Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
